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U rothelial carcinoma of the upper urinary tract (UTUC) is uncommon,  accounting for less than 
5% of all urothelial carcinomas (UCs) [1-2].  Standard 
diagnostic methods for UTUC include upper-tract 
imaging (CT urography [CTU] is the first-line) and 
urine cytology [3].  The detection rate of UTUC is satis-
factory with high specificity for CT urography in paral-
lel with the development of CT devices [4].  Current 
indications for nephro-ureterectomy with ipsilateral 
bladder cuff excision include cases of suspected UTUC 
based on imaging and positive urine cytology.  However,  
there are minor cases with consistently positive urine 
cytology that show poorly detectable lesions in the 
upper urinary tract,  i.e.,  filling defects and/or wall 
thickness,  on imaging studies.  Such cases in whom 
lower urinary tract malignancy has been excluded are 
suspected of flat UTUC or carcinoma in situ of the upper 
tract (UT-Cis).  However,  there is poor evidence of effi-
cient diagnostic options for such cases.
Ureteroscopy (URS) for the upper urinary tract was 
previously a relatively invasive work-up with common 
adverse effects.  Recently,  small-diameter,  flexible,  
high-resolution ureteroscopes have enabled safe access 
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We elucidate the fate of cases clinically suspected of carcinoma in situ (Cis) of the upper tract with serial uret-
eroscopy.  Of 143 patients who underwent ureteroscopy for suspected upper tract urothelial carcinoma (UTUC) 
between January 2008 and February 2016,  12 cases with consistently positive urine cytology and poorly detect-
able upper-tract malignancies by imaging were reviewed.  In these 12 patients,  19 ureteroscopy procedures (25 
renal units) were performed.  Vesical random biopsy was performed before the 1st ureteroscopy to exclude 
malignancy of the bladder in all 12 cases.  Median follow-up was 42 (13-67) months.  Positive biopsy results at 
the 1st ureteroscopy were obtained in 3 (25%) patients and all were diagnosed wth Cis of the upper tract.  Two 
(17%) of 9 patients who were negative or inconclusive at the 1st ureteroscopy were finally diagnosed as UTUC,  
but plural ureteroscopy procedures were needed for the diagnoses in both.  Carcinoma of the bladder appeared 
in 5 (42%) patients during follow-up,  despite the earlier ruling out of vesical malignancy.  Four (33%) of those 5 
patients never developed upper-tract urothelial carcinoma during follow-up.  Caution is required before under-
taking radical surgery for cases clinically suspected of Cis of the upper tract.  In our experience,  only 42% of 
such patients developed UTUC; another 33% eventually developed carcinoma of the bladder without UTUC.
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to the upper tract and enable tissue to be obtained easily 
at biopsy; hence,  current URS is a valuable tool for 
diagnosis of upper-urinary-tract disorders.
We have performed URS for upper-urinary-tract 
disorders for more than 2 decades,  and have reported 
the usefulness of URS for diagnosing and treating idio-
pathic renal bleeding [5],  and for detecting small,  low-
grade upper tract tumors and prescribing neph-
ron-sparing treatment options [6].  In this study,  we 
assess the usefulness of diagnostic URS for cases with 
consistently positive cytology and upper-urinary-tract 
lesions that are poorly detectable on imaging.  We also 
report the final diagnoses of these cases during fol-
low-up.
Materials and Methods
After approval from the Okayama University 
Hospital Institutional review board and an ethics com-
mittee review board (No. 1604-505-001),  143 clinical 
records of patients undergoing URS evaluation for sus-
pected UTUC at our institution between January 2008 
and February 2016 were reviewed.  Of 143 patients,  12 
cases were highlighted as having consistently positive 
urine cytology (class IV or V on cytological evaluation) 
and poorly detectable malignant lesions in the upper 
urinary tract on imaging.  The standard imaging 
method was enhanced CT urography; in patients for 
whom iodinated contrast media were contraindicated,  
MR urography was used instead.  Cystoscopy and vesi-
cal mucosa random biopsy (including prostatic urethra 
in men) were performed in all 12 cases before the 1st 
URS to exclude malignancy of the bladder.
URS procedures at our institution are as follows.  
Under general anesthesia,  ureteral orifice and lower 
ureter are first observed using a rigid ureteroscope 
(Fibre Uretero-Renoscope,  Richard-Wolf,  Knittlingen,  
Germany).  The middle and upper ureter and pelvis are 
observed next using a flexible ureteroscope (URF-P5,  
URF-P6,  Olympus,  Tokyo,  Japan).  If clinicians detect 
lesions suspected of malignancy—i.e.  irregular,  edem-
atous,  reddish mucosa—a biopsy is performed with 
3-Fr biopsy cup forceps (Cook Japan,  Tokyo,  Japan).  
Three tissue samples are usually obtained at biopsy.
We evaluated whether diagnostic URS could detect 
UTUC that imaging studies could not detect decisively.  
We also evaluated the final diagnoses of the 12 patients 
examined.
Results
Median follow-up was 42 (13-67) months.  Patient 
backgrounds of the 12 cases are summarized in Table 1.  
Six of the 12 patients had a previous history of bladder 
cancer (Cis; 3 patients,  Non-Cis; 3 patients).  The 1st 
URS was performed after excluding present malignancy 
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Table 1　 Patient characteristics,  urine cytology,  imaging ﬁndings and ﬁnal diagnosis
Pt. No. Sex Age Urine cytology before URS
Imaging before 
URS
Previous history of 
Bladder cancer Final diagnosis
1 Male 73 V CT none UTUC (non-Cis)
2 Male 70 V CT none Cis of the bladder
3 Female 77 V CT non-Cis UC of the bladder (non-Cis)
4 Female 63 V CT Cis no malignancy (followed up)
5 Male 69 V CT non-Cis Cis of the bladder
6 Male 69 V CT Cis UT-Cis
7 Female 61 IV CT,  MRI none Cis of the bladder→UTUC (non-Cis)
8 Female 75 V CT Cis UT-Cis
9 Male 43 IV CT none no malignancy (followed up)
10 Female 62 V CT none no malignancy (followed up)
11 Female 53 V CT non-Cis Cis of the bladder
12 Male 66 V CT,  MRI non UT-Cis
of the bladder in each of the 12 patients.  Three cases of 
UT-Cis were diagnosed histologically at the 1st URS.  
Two of these 3 UT-Cis cases diagnosed at the 1st URS 
had a previous history of Cis of the bladder.  Two of the 
9 patients who were not diagnosed with UTUC histo-
logically at the 1st URS were considered to be clinical 
UT-Cis,  and received intrarenal Bacillus Calmette-
Guerin (BCG) therapy.  In one patient the positive urine 
cytology disappeared,  and this patient was followed up.  
Another patient showed a consistently positive cytology 
and a 2nd URS was considered.  Another 7 of the 9 
patients who were not diagnosed with UTUC histolog-
ically at the 1st URS were followed up; in 2 of these 7 
patients,  positive urine cytology disappeared but fol-
low-up was continued.  Another 3 of the 7 patients 
showed a new appearance of Cis of the bladder.  Another 
2 of the 7 patients continued positive cytology and a 
2nd URS was considered.  Ultimately 3 patients received 
a 2nd URS and all failed to diagnose UTUC histologi-
cally.  One of the 3 patients who received a 2nd URS 
were considered to have clinical UT-Cis,  and received 
intrarenal BCG therapy,  but was finally diagnosed with 
UTUC (non-Cis) in imaging during follow-up.  
Another patient,  who showed a new appearance of Cis 
of the bladder during follow-up,  received intravesical 
BCG therapy with Cis disappearing histologically after 
treatment,  but was finally considered for a 3rd URS 
because of recurrent positive cytology during follow-up.  
Another patient continued to show positive cytology 
and a 3rd URS was considered.  Ultimately,  2 patients 
received a 3rd URS.  One of these 2 patients who 
received a 3rd URS was histologically diagnosed with 
UTUC (non-cis).  Another patient who was not diag-
nosed with UTUC histologically at the 3rd URS was 
ultimately diagnosed with bladder cancer (non-Cis) 
during follow-up.  A summary of clinical progress and 
results are shown in Fig. 1.
In summary,  a total of 19 URS procedures (25 renal 
units) were performed in 12 patients with consistently 
positive cytology and no or poorly detectable upper-
urinary-tract lesions on imaging.  In these 19 URS pro-
cedures,  17 biopsies (17 renal units) were performed.  
Of these 12 cases,  UT-Cis was histologically diagnosed 
in 3 patients at 1st URS.  Non-cis of the upper tract was 
ultimately diagnosed in 2 patients,  but plural URS pro-
cedures were needed for the diagnosis in both.  Five 
patients developed carcinoma of the bladder during 
follow-up,  despite vesical malignancy having been 
ruled out by mucosa biopsy.  In 2 patients positive urine 
cytology disappeared after the 1st URS,  and follow-up 
was continued without any symptoms or suspicions 
signs on imaging.
Discussion
The European Association of Urology (EAU) guide-
line on UTUC includes cytological evaluation of urine,  
cystoscopy to exclude malignancy of the bladder,  and 
imaging as the standard diagnostic work-up [3].  CTU 
is the standard imaging method,  and has replaced 
intravenous excretory urography.  The detection rate of 
UTUC is satisfactory for CTU,  with both high sensitiv-
ity and specificity.  In addition,  the wall thickness of the 
upper tract on CTU is considered to be a sign of UTUC,  
even when there is no luminal mass effect.  However,  
sensitivity drops for small or flat lesions even with the 
latest CTU [7].  Patients who cannot undergo CTU due 
to contraindication of iodinated contrast media typi-
cally undergo MR urography,  the detection rate of 
which is less than that of CTU [8].  The usefulness of 
diffusion-weighted MR for improving cancer detection 
has been reported [9].  The diffusion coefficient values 
of highly malignant tumors have been reported to be 
lower than those of less malignant tumors.  However,  
diffusion-weighted MR cannot detect UT-Cis,  which is 
a highly malignant tumor.  Asai et al.  reported an out-
standing positive predictive value (PPV) of 95% in 
diagnoses of UTUC using fluorodeoxyglucose positron 
emission tomography/computed tomography (PET-CT),  
a new imaging option [10],  but with the limitation that 
this sensitivity is lower in diabetic patients.  PET-CT 
also cannot detect UT-Cis.
Application of diagnostic URS for evaluating sus-
pected UTUC is controversial,  with low-grade evidence 
supporting either view [3 , 11].  Some updated reports 
value URS not only as a diagnostic tool but also as an 
endoscopic management tool for UTUC,  with recent 
small-diameter,  flexible,  high-resolution ureteroscopes 
resulting in satisfactory safety and ease of work-up 
[12 , 13].  One report found that the technical success 
rate of URS in UTUC patients was 95%,  and that biop-
sies using such ureteroscopes could obtain a satisfactory 
accurate diagnostic tumor grade regardless of sample 
size [14].  Tsivian et al.  reported that routine use of 
diagnostic URS in the evaluation of suspected UTUC 
reduced misdiagnoses (non-UC with final pathologic 
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Fig. 1　 Summary of clinical progress and results of 12 patients.
findings) [15].  They also emphasized that URS evalua-
tion appeared to increase other nephron-sparing treat-
ment options.  However,  these reports do not mention 
the type of UTUC,  nor the definition of suspected 
UTUC (suspected with imaging study or urine cytol-
ogy).
We have adopted routine URS in the evaluation of 
suspected UTUC,  and have reported the possibility of 
cancer control for nephron-sparing treatment options 
under URS [16].  In the present report,  we focus on 
cases with consistently positive cytology and upper-
urinary-tract lesions poorly detectable by imaging such 
as CTU,  and evaluated the usefulness of diagnostic URS 
for such cases.  Cis of the upper tract was diagnosed 
histologically in only 3 of the 12 patients,  but all 3 cases 
were diagnosed at the 1st URS.  Two of these 3 UT-Cis 
cases had a previous history of Cis of the bladder.  These 
results indicate that URS is useful and should be 
strongly considered for detecting UT-Cis in patients 
with a previous history of Cis of the bladder.
Another finding from our present data is that carci-
noma of the bladder ultimately appeared in more than 
40% of the patients during follow-up,  regardless of ves-
ical malignancy having been ruled out before URS.  
These cases must have had a very small area of carci-
noma that could not be detected with a random vesical 
mucosa biopsy but produced the consistently positive 
cytology and were finally diagnosed as bladder cancer.  
The number of patients with carcinoma of the bladder 
was greater than that of patients with UT-Cis.  Benign 
pathologic results were detected when these patients 
underwent radical nephro-ureterectomy.  Indeed,  Hong 
et al.  report the incidence of benign results after laparo-
scopic radical nephro-ureterectomy with preoperative 
suspicion of UTUC,  and indicate the need for careful 
and thorough preoperative counseling [16].  Our small 
sample of data may suggest that radical nephro-ureter-
ectomy requires caution,  and that frequent follow-up 
with urine cytology and imaging studies,  and/or possi-
ble URS,  should be considered for cases clinically sus-
pected of UT-Cis due to consistently positive cytology 
and upper-urinary-tract lesions poorly detectable by 
imaging.
One concern from our data is that in 2 of 12 patients 
in whom URS did not detect UC lesions,  positive urine 
cytology disappeared after URS.  Reports that the PPV 
of urine cytology for UTUC is generally very high [17],  
and that identification of UT-Cis lesions under URS is 
not satisfactory [12] suggest that these 2 patients would 
need strict follow-up.
The findings of this study have some limitations.  
First,  the retrospective nature of the study must be 
taken into account.  Second,  the 12 patients evaluated 
in the study include those with a past history of bladder 
cancer,  although the random biopsy of vesical mucosa 
ruled out malignancy of the bladder prior to URS.  In 
addition,  we did not evaluate upper tract selective 
cytology (UTC) because catheterization for collecting 
urine samples from the upper tract could produce mis-
leading results.  Namely,  catheterization can affect the 
cellularity and nuclear morphology of a urine sample 
[18].  The procedure may also affect the morphology of 
the upper tract mucosa,  making the mucosa mimic Cis.  
Finally,  the small sample size prevents us from reaching 
statistical conclusions.  Our results need to be con-
firmed with well-designed observational studies.
URS was performed only under white light (WL) in 
this study.  Recent developments in optical diagnostics 
have been reported to improve the diagnostic accuracy 
of UTUC [19].  Traxer et al.  report that the URS tumor 
detection rate was improved by 22.7% using narrow- 
band imaging (NBI) technology,  and that in 27 patients,  
5 additional tumors that were considered normal under 
WL could be detected under NBI,  suggesting the use-
fulness of the technology for detecting UTUC by URS 
[20].  We should also consider routine URS using these 
new optical diagnostics technologies,  although evi-
dence of daily clinical use is still insufficient.
The present study concluded that radical surgery 
should be approached with caution,  and frequent fol-
low-up with urine cytology and imaging studies,  and/or 
possible URS,  should be considered in cases in whom 
UT-Cis is suspected due to consistently positive cytol-
ogy and upper-urinary-tract lesions that are poorly 
detectable by imaging.  Biopsy under URS should be 
strongly considered for cases with a previous history of 
Cis of the bladder.
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